17 studies found for:    Open Studies | "Epistaxis"
Show Display Options
Rank Status Study
1 Recruiting Intranasal Bevacizumab for HHT-Related Epistaxis
Conditions: HHT;   Hereditary Hemorrhagic Telangiectasia;   Epistaxis;   Nose Bleeds;   Nasal Bleeding
Intervention: Drug: Bevacizumab
2 Recruiting Efficacy of a Bevacizumab Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Conditions: Hereditary Hemorrhagic Telangiectasia;   Epistaxis
Interventions: Drug: Bevacizumab;   Drug: placebo
3 Unknown  A Prospective Randomised Controlled Trial of Management of Recurrent Nosebleeds in Children
Condition: Epistaxis
Intervention: Procedure: Nasal Cautery
4 Unknown  Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia
Conditions: Hereditary Hemorrhagic Telangiectasia;   Epistaxis
Intervention: Drug: Thalidomide
5 Not yet recruiting Management of Persistent Epistaxis Using Floseal Hemostatic Matrix
Condition: Epistaxis
Interventions: Device: Floseal Hemostatic Matrix;   Procedure: Traditional Nasal Packing
6 Recruiting Long Term Results and Complications After Epistaxis Treatment
Condition: Nosebleed (Epistaxis) - Posterior or Anterior
Intervention:
7 Recruiting Nasal Intubation Using a Parker Flex-tip Endotracheal Tube Compared to a Nasal RAE Tube
Condition: Epistaxis
Interventions: Device: Nasal Intubation with nasal RAE endotracheal tube;   Device: Nasal Intubation with Parker Flex-Tip endotracheal tube
8 Recruiting Hemoglobin and INR Out of Nose Blood
Condition: Epistaxis
Intervention:
9 Recruiting Nasal Saline Irrigation After Radiation Therapy for Oropharyngeal Cancer
Conditions: Nasal Obstruction;   Rhinitis, Vasomotor;   Epistaxis
Intervention: Other: Saline mixture
10 Recruiting The Effect of Intranasal Vasoconstrictor Medications on Hemodynamic Parameters: A Randomized Double-blind, Placebo-controlled Trial.
Conditions: Epistaxis;   Blood Pressure
Interventions: Drug: Oxymetazoline 0.05%;   Drug: Phenylephrine 0.25%;   Drug: Lidocaine 1% plus epinephrine 1:100,000;   Drug: Bacteriostatic 0.9% NaCL
11 Unknown  Double Versus Single Pledget Nasal Anesthesia for Transnasal Endoscopy
Conditions: Anesthesia;   Epistaxis
Interventions: Device: Double pledget nasal anesthesia (DPNA);   Device: Single pledget nasal anesthesia (SPNA)
12 Unknown  Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Condition: Hereditary Hemorrhagic Telangiectasia (HHT)
Intervention: Drug: Submucosal Bevacizumab
13 Unknown  A Novel Anterior Rhinoscopic Scoring Scale to Predict Nasal Insertability Before Transnasal Endoscopy
Conditions: Injury Due to Endoscopic Examination;   Transnasal Endoscopy Induced Epistaxis;   Transnasal Endoscopy Induced Nasal Pain
Interventions: Procedure: anterior meatoscopy;   Procedure: Nasal sniff test
14 Unknown  Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Condition: Hereditary Hemorrhagic Telangiectasia (HHT)
Intervention: Drug: Bevacizumab
15 Recruiting Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - Randomized Trial Versus Placebo
Condition: Hemorrhagic Hereditary Telangiectasia (HHT)
Interventions: Drug: Timolol nasal spray;   Drug: Placebo nasal spray
16 Recruiting Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective Dose
Condition: Telangiectasia, Hereditary Hemorrhagic
Intervention: Drug: bevacuzimab spray
17 Recruiting Iron Deficiency and Hereditary Haemorrhagic Telangiectasia
Condition: Hereditary Haemorrhagic Telangiectasia
Intervention: Drug: Ferrous sulphate 200mg oral tablet

Indicates status has not been verified in more than two years